BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 12040467)

  • 1. Extracorporeal photopheresis in chronic graft-versus-host disease.
    Foss FM; Gorgun G; Miller KB
    Bone Marrow Transplant; 2002 May; 29(9):719-25. PubMed ID: 12040467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.
    Apisarnthanarax N; Donato M; Körbling M; Couriel D; Gajewski J; Giralt S; Khouri I; Hosing C; Champlin R; Duvic M; Anderlini P
    Bone Marrow Transplant; 2003 Mar; 31(6):459-65. PubMed ID: 12665841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of extracorporeal photopheresis on intracellular cytokine expression in chronic cutaneous graft-versus-host disease.
    Darvay A; Salooja N; Russell-Jones R
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):279-84. PubMed ID: 15096136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host disease.
    Spisek R; Gasova Z; Bartunkova J
    Transfusion; 2006 Jan; 46(1):55-65. PubMed ID: 16398731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease.
    Fimiani M; Di Renzo M; Rubegni P
    Br J Dermatol; 2004 Jun; 150(6):1055-60. PubMed ID: 15214889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of graft versus host disease (GVHD) by photopheresis?
    Schooneman F; Claise C
    Transfus Sci; 1996 Dec; 17(4):527-36. PubMed ID: 10168550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocytes treated by extracorporeal photopheresis can down-regulate cytokine production in untreated monocytes.
    Bladon J; Taylor PC
    Photodermatol Photoimmunol Photomed; 2005 Dec; 21(6):293-302. PubMed ID: 16313240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal photophoresis increases sensitivity of monocytes from patients with graft-versus-host disease to HLA-DR-mediated cell death.
    Setterblad N; Garban F; Weigl R; Assier E; Drillat P; Charron D; Dickinson A; Greinix H; Mooney N
    Transfusion; 2008 Jan; 48(1):169-77. PubMed ID: 17900279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?
    Couriel D; Hosing C; Saliba R; Shpall EJ; Andelini P; Popat U; Donato M; Champlin R
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):37-40. PubMed ID: 16399600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technology insight: ECP for the treatment of GvHD--can we offer selective immune control without generalized immunosuppression?
    Marshall SR
    Nat Clin Pract Oncol; 2006 Jun; 3(6):302-14. PubMed ID: 16757968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis.
    Yamashita K; Horwitz ME; Kwatemaa A; Nomicos E; Castro K; Sokolic R; Foster SF; Garofalo M; Choi U; Ryherd M; Brown MR; Leitman SF; Wayne AS; Fowler DH; Bishop MR; Childs RW; Barrett AJ; Pavletic SZ; Malech HL
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):22-30. PubMed ID: 16399598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graft-versus-host disease after allogeneic stem cell transplantation: evolving concepts and novel therapies including photopheresis.
    Komanduri KV; Couriel D; Champlin RE
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):1-6. PubMed ID: 16399595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD).
    Child FJ; Ratnavel R; Watkins P; Samson D; Apperley J; Ball J; Taylor P; Russell-Jones R
    Bone Marrow Transplant; 1999 May; 23(9):881-7. PubMed ID: 10338042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal photopheresis for steroid resistant graft versus host disease in pediatric patients: a pilot single institution report.
    Berger M; Pessolano R; Albiani R; Asaftei S; Barat V; Carraro F; Biasin E; Madon E; Fagioli F
    J Pediatr Hematol Oncol; 2007 Oct; 29(10):678-87. PubMed ID: 17921848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease.
    Ilhan O; Arat M; Arslan O; Ayyildiz E; Sanli H; Beksac M; Ozcan M; Gürman G; Akan H
    Transfus Apher Sci; 2004 Jun; 30(3):185-7. PubMed ID: 15172621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of extensive chronic graft-versus-host disease with extracorporeal photochemotherapy.
    Bisaccia E; Palangio M; Gonzalez J; Adler KR; Scarborough R; Goldberg SL; Rowley SD
    J Clin Apher; 2006 Oct; 21(3):181-7. PubMed ID: 16607632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ECP-treated lymphocytes of chronic graft-versus-host disease patients undergo apoptosis which involves both the Fas/FasL system and the Bcl-2 protein family.
    Di Renzo M; Rubegni P; Sbano P; Cuccia A; Castagnini C; Pompella G; Pasqui AL; Capecchi PL; Auteri A; Laghi Pasini F; Fimiani M
    Arch Dermatol Res; 2003 Sep; 295(5):175-82. PubMed ID: 12883827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature.
    Kanold J; Merlin E; Halle P; Paillard C; Marabelle A; Rapatel C; Evrard B; Berger C; Stephan JL; Galambrun C; Piguet C; D'Incan M; Bordigoni P; Deméocq F
    Transfusion; 2007 Dec; 47(12):2276-89. PubMed ID: 17764513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Extracorporeal photopheresis in the treatment of patients with refractory chronic graft-versus-host disease after allogeneic bone marrow transplantation].
    Bykova TA; Kozlov AV; Stancheva NV; Semënova EV; Kulagina II; Bondarenko SN; Vavilov VN; Morozova EV; Zubarovskaia LS; Afanas'ev BV
    Ter Arkh; 2013; 85(8):60-8. PubMed ID: 24137966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracorporeal photopheresis normalizes some lymphocyte subsets (including T regulatory cells) in chronic graft-versus-host-disease.
    Bladon J; Taylor P
    Ther Apher Dial; 2008 Aug; 12(4):311-8. PubMed ID: 18789119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.